Previous 10 | Next 10 |
ICON Public Limited Company is a leading clinical research organization, aiding researchers and companies across the entire industry in performing their work. The healthcare industry is extremely strong at the moment and set to see favorable tailwinds over the next few years. I be...
ICON plc (NASDAQ:ICLR) traded at a new 52-week high today of $251.61. This new high was reached on below average trading volume as 107,000 shares traded hands, while the average 30-day volume is approximately 843,000 shares. ICON plc (NASDAQ:ICLR) is currently priced 10.4% above its aver...
ICON plc (NASDAQ:ICLR) traded today at a new 52-week high of $249.00. This new high was reached on below average trading volume as 107,000 shares traded hands, while the average 30-day volume is approximately 1.4 million shares. ICON plc share prices have moved between a 52-week high of ...
Shares of ICON plc (NASDAQ:ICLR) traded today at $245.47, eclipsing its 52-week high. Approximately 107,000 shares have changed hands today, as compared to an average 30-day volume of 1.4 million shares. Icon is a global late-stage contract research organization that provides drug develo...
ICON plc (NASDAQ:ICLR) traded at a new 52-week high today of $239.06. So far today approximately 107,000 shares have been exchanged, as compared to an average 30-day volume of 1.3 million shares. ICON plc share prices have moved between a 52-week high of $239.06 and a 52-week low of $168...
Image source: The Motley Fool. Icon PLC (NASDAQ: ICLR) Q2 2021 Earnings Call Jul 22, 2021 , 9:00 a.m. ET Operator Continue reading For further details see: Icon PLC (ICLR) Q2 2021 Earnings Call Transcript
The following slide deck was published by ICON Public Limited Company in conjunction with their 2021 Q2 earnings call. For further details see: ICON Public Limited Company 2021 Q2 - Results - Earnings Call Presentation
ICON Public Limited Company (ICLR) Q2 2021 Earnings Conference Call July 22, 2021, 9:00 AM ET Company Participants Jonathan Curtain - Vice President, Corporate Finance and Investor Relations Brendan Brennan - Chief Financial Officer Steve Cutler - Chief Executive Officer Conference Call Parti...
Highlights Record net business wins in the quarter of $1,106 million, an increase of 21.6% year on year; a net book to bill of 1.27. Record closing backlog of $10.2 billion, an increase of 12.7% year on year. Quarter 2 reported revenue of $871.2 million represe...
Over 70 multi-billion dollar deals announced in the first half of the year. SPAC IPOs pick up pace and Chamath Palihapitiya files four new biotech focused SPACs. Icon completes the acquisition of PRA Health Sciences. For further details see: Merger Arbitrage Mondays - MK...
News, Short Squeeze, Breakout and More Instantly...
ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2024 with a number of leading business and industry awards recognising the company’s leadership position in the clinical research industry, in addi...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the second quarter 2024 after the market closes on Wednesday, July 24, 2024. The company will hold a conference call and webcas...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 1:30pm ET. Any changes to this event and links...